Skip to main content


Figure 1 | Journal of Translational Medicine

Figure 1

From: The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing

Figure 1

Representative results of the different staining methods. Intestinal tumor (hematoxylin and eosin (H&E), A.1, 20x) with IHC 3+ (immunohistochemistry (IHC), A.2, 20x; gene/protein, A.4, 20x) and amplification (silver in situ hybridization (SISH), A.3, 40x; gene/protein, A.4, 20x). IHC score 0 (IHC, B.2, 20x; gene/protein, B.4, 40x), intestinal type (H&E, B.1, 20x) and amplification (SISH, B.3, 40x; gene/protein, B.4, 40x).

Back to article page